Phaxiam Therapeutics (0QSS)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 4.14M | 3.36M | 4.45M | 5.28M | 3.72M | 4.18M | 6.65M | 1.33M |
| Operating Income | -22.39M | -30.89M | -43.62M | -64M | -68.83M | -56.52M | -27.15M | -23.37M |
| Pre Tax Income | -21.9M | -33.53M | -38.22M | -62.66M | -73.3M | -53.8M | 293k | -23.7M |
| Net Income | -21.91M | -33.53M | -38.22M | -62.66M | -73.3M | -53.8M | -228k | -23.49M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -2.51 | -1.869 | -2.131 | -3.493 | -3.655 | -1.734 | -0.007 | -3.866 |
| EBIT | -22.39M | -30.89M | -43.62M | -64.07M | -68.83M | -56.52M | -27.15M | -23.66M |
| EBITDA | -21.96M | -30.36M | -42.82M | -59.79M | -63.84M | -51.14M | -22.53M | -21.76M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
